Abstract:Five new ruthenium(II) polypyridyl complexes [Ru(N–N)2(BTCP)](ClO4)2 (BTCP = 2-(bicyclo[2.2.1]hept-5-en-2-yl)-1H-imidazo[4,5-f][1,10]phenanthroline; N–N = dmb: 4,4′-dimethyl-2,2′-bipyridine, 1; bpy: 2,2′-bipyridine 2; ttbpy: ditertairy-butyl-2,2′-bipyridine 3; phen: 1,10-phenanthroline 4; dmp: 2,9-dimethyl-1,10-phenanthroline 5) were synthesized and characterized by elemental analysis, IR, ESI-MS, 1H NMR and 13C NMR. The DNA-binding behaviors were studied by electronic absorption titration, viscosity measurements and molecular docking. The results show that complexes 1–4 interact with CT-DNA through intercalative modes, whereas complex 5 interacts through a partial intercalative mode. The DNA-binding constants follow the order of 3 > 4 > 1 > 2 > 5. The cytotoxic activity of the complexes against SGC-7901, PC-12, SiHa, HepG2, BEL-7402, A549 and HeLa cancer cell lines was evaluated by MTT method. The complexes display moderate cytotoxic activity toward BEL-7402 cells with an IC50 value of 25.5 ± 1.3 µM for 1, 45.7 ± 4.2 µM for 2, 6.5 ± 0.4 µM for 3, 13.2 ± 1.2 µM for 4 and 9.1 ± 1.1 µM for 5, respectively. Complex 5 exhibits the highest cytotoxic effect on the cell growth in SGC-7901, HepG2 and A549 cells among the complexes. The cytotoxic activity of the complexes is not consistent with the order of their DNA-binding constants. The apoptosis of BEL-7402 cells was studied under a fluorescent microscope and by flow cytometry. Measurements of reactive oxygen species, mitochondrial membrane potential and comet assays were carried out. The cell cycle arrest was investigated by flow cytometry, and the results demonstrate that complexes 1, 2, 4 and 5 inhibit the cell growth at G0/G1 phase and complex 3 induces cell cycle arrest at G2/M phase in BEL-7402 cells. The expression of Bcl-2 family induced by the complexes was studied by western blot. The results obtained show that complexes induce apoptosis in BEL-7402 cells through action of DNA and ROS-mediated mitochondrial dysfunction pathways.

Synthesis, Cytotoxicity and Anti‐metastatic Properties of New Pyridyl–thiazole Arene Ruthenium(ii) Complexes

Synthesis, characterization, and anticancer activity of Ru( p -cymene) complexes bearing pyrazolyl–pyridine type ligands

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes

Synthesis of Novel NHC–Rh Complexes with Anti-Tumor Activity Against MCF-7 Human Breast Cancer Cells

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Study on antitumor activity of three ruthenium arene complexes in vitro

Anticancer and antimicrobial properties of novel η6- p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands.

New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies

Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands

Ligand-Based Neutral Ruthenium(Ii) Arene Complex: Selective Anticancer Action

Polynuclear ruthenium organometallic complexes containing a 1,3,5-triazine ligand: synthesis, DNA interaction, and biological activity

Cyclometalated Ru(II)-NHC Complexes with Phenanthroline Ligand Induce Apoptosis Mediated by Mitochondria and Endoplasmic Reticulum Stress in Cancer Cells

Mononuclear η6-arene ruthenium(II) complexes with pyrazolyl-pyridazine ligands: synthesis, CT-DNA binding, reactivity towards glutathione, and cytotoxicity